Thread by @JCedernaes

"“Our scientific position is that this vaccine is a safe and effective option to protect citizens against COVID-19,” said the head of the EMA, Emer Cooke.

She added: “If it were me, I would be vaccinated tomorrow.”"

abcnews.go.com/Technology/wir…

https://twitter.com/DrEkstrom/status/1372581836619141126

2) However, the EMA “cannot rule out definitively a link” between the rare types of blood clots and the vaccine.

They are therefore recommending to add a description that such cases have been reported, to the vaccine leaflets, to make health workers and patients aware of this.

3) Note however that this would be a very rare event, 37 or slightly more out of 17 M recipients, bringing the reported ratio to ~ the reported rate of anaphylaxis for Pfizer & Moderna (2.5-4.7 per 1 million doses) - just from a numbers comparison.
jamanetwork.com/journals/jama/…

4) @EMA_News:

"considers that the benefit-risk balance of the medicine remains positive, & there is no association with thromboembolic disorders overall. However, steps will be taken to update the SmPC & package leaflet with information on cases of DIC & CVST that have occurred"

5) The EMA acknowledges that there have been very rare (n=5 out of ~20 M) cases of an unusual type of disrupted coagulation (DIC) after vaccination. These cases were mostly seen in women under the age of 55, but casuality cannot be confirmed or excluded.
ema.europa.eu/en/news/covid-…